PHARMACOLOGICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2024-01-03 1225de92m39暂无昵称来自广东省

请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？

19 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2023-02-14 FPW 来自江苏省

想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2019-09-03 letitia

请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表:
我上传了平行的三次结果，大部分结果的marker可见。

SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。

149 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2022-09-24 ms1000001879726925

22号Required Reviews Completed，24号又变成under review，什么情况？？？

40 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2022-07-16 待我慢慢

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：拒稿后修改重新投稿;综述
经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？

43 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2021-09-06 漱石先生

审稿速度:2.0
偏重的研究方向：动物模型;药理;药效
经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。

303 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2020-06-12 ms6596549308483070

审稿速度:2.0
经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~

135 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2021-03-22 小心晴、

大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？

165 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2021-05-05 konglingwen88

请问这期刊有子刊吗？modern chinese medicine是什么？

80 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014910, encodeId=024f1014910c8, content=审稿速度:2.0 偏重的研究方向：动物模型;药理;药效 经验分享：最近刚被接受了一篇，编辑很专业，很速度。总的来说该杂志相对严谨，口碑好，在药理学方向上是首选杂志之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=sjboYJOybSUb6icdcZuRz5g&s=100&t=1556619289, createdBy=dba85289590, createdName=漱石先生, createdTime=Mon Sep 06 04:45:37 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861778, encodeId=53f2861e786e, content=审稿速度:2.0 经验分享：审稿速度很快，一个多月给意见，很幸运只是小问题，修改了语法和内容调整，修回了6天就接收了，第一篇sci~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Fri Jun 12 09:24:54 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950053, encodeId=44949500530a, content=大家最近有在这个期刊投稿吗？为什么在生成PDF的时候总是提示error呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/10/b6d7f398c3f87c6d9ce31ed6c576ea1a.jpg, createdBy=879d2500515, createdName=小心晴、, createdTime=Mon Mar 22 09:44:18 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962823, encodeId=7bea9628239e, content=请问这期刊有子刊吗？modern chinese medicine是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9588101200, createdName=konglingwen88, createdTime=Wed May 05 16:04:12 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111917, encodeId=4d29211191e72, content=请问这个期刊允许有共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Sat Jan 28 23:34:30 CST 2023, time=2023-01-28, status=1, ipAttribution=河北省)]

2023-01-28 ms5000000640975514 来自河北省

请问这个期刊允许有共同第一作者吗

47 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务